{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:31:07Z","timestamp":1787020267399,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"St. Elisabeth Gruppe GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Fetal lower urinary tract obstruction (LUTO) is a rare congenital disease associated with high morbidity and mortality due to pulmonary hypoplasia and renal insufficiency. Fetal management includes early vesicoamniotic shunting (VAS), a technique that has evolved in recent years to preserve kidney function. Previous publications have focused on intrauterine shunt complications, such as dislocation and preterm premature rupture of membranes (PPROM). In our study we aimed to assess postnatal shunt related complications that became obvious after birth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      We describe our preliminary experience with 25 fetuses who underwent VAS with a Somatex\n                      <jats:sup>\u00ae<\/jats:sup>\n                      shunt as well as postnatal shunt removal at two experienced centers for fetal medicine. The intrauterine course, underlying pathology, postnatal outcome and details on shunt explantation and related complications were assessed. The data were retrospectively analysed in relation to the intrauterine course, underlying pathology, further malformations, and perioperative characteristics with a focus on the complication spectrum and type of intervention.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-five fetuses underwent VAS at a median of 17 weeks. Two newborns were excluded because they died within the first 24 hours of life secondary to fulminant lung hypoplasia. In ten (43%) newborns, shunt removal was performed under local anaesthesia. In 13 (57%) neonates, the shunt was explanted surgically, and five (22%) of these operations were defined as complex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Intrauterine VAS with a Somatex\n                      <jats:sup>\u00ae<\/jats:sup>\n                      shunt is feasible, and in the majority of cases, shunt explantation can be easily performed after birth. However, the umbrellas may cause intraabdominal tissue damage, peritoneal adhesions or skin defects, and early surgical management of VAS associated complications might be necessary.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-025-05457-3","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:49:17Z","timestamp":1740379757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Postnatal surgical complications in lower urinary tract obstruction following fetal vesico- amniotic shunting"],"prefix":"10.1186","volume":"25","author":[{"given":"Anna","family":"Me\u00dfling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Hubertus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Heydweiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"5457_CR1","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1471-0528.2012.03476.x","volume":"119","author":"G Malin","year":"2012","unstructured":"Malin G, Tonks AM, Morris RK, Gardosi J, Kilby MD. Congenital lower urinary tract obstruction: a population- based epidemiological study. BJOG. 2012;119:1455\u201364. https:\/\/doi.org\/10.1111\/j.1471-0528.2012.03476.x.","journal-title":"BJOG."},{"key":"5457_CR2","doi-asserted-by":"publisher","unstructured":"Schierbaum, Luca M et al. \u201cGenome-Wide Survey for Microdeletions or -Duplications in 155 Patients with Lower Urinary Tract Obstructions (LUTO).\u201d Genes (2021) https:\/\/doi.org\/10.3390\/genes12091449","DOI":"10.3390\/genes12091449"},{"key":"5457_CR3","first-page":"273","volume-title":"Fetal therapy: invasive and transplacental","author":"DC Merrill","year":"1997","unstructured":"Merrill DC, Weiner CP. Urinary tract obstruction. In: Fisk NM, Moise KJ, editors. Fetal therapy: invasive and transplacental. Cambridge: Cambridge University Press; 1997. p. 273\u201386."},{"key":"5457_CR4","doi-asserted-by":"publisher","unstructured":"Freedman AL, Johnson MP, Gonzalez R. Fetal therapy for obstructive uropathy: past, present.future? Pediatr Nephrol. 2000;14(2):167\u201376. https:\/\/doi.org\/10.1007\/s004670050035.\u00a0","DOI":"10.1007\/s004670050035"},{"key":"5457_CR5","doi-asserted-by":"publisher","unstructured":"Morris RK, KS Khan, Kilby MD. Vesicoamniotic shunting for fetal lower urinary tract obstruction: an overview. Arch Dis Child Fetal Neonatal ED 2007; 92: F166-168. https:\/\/doi.org\/10.1136\/adc.2006.099820","DOI":"10.1136\/adc.2006.099820"},{"key":"5457_CR6","doi-asserted-by":"publisher","unstructured":"Osborne, Newton G et al. Fetal megacystis: differential diagnosis. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.\u00a02011;30(6):833-41.\u00a0https:\/\/doi.org\/10.7863\/jum.2011.30.6.833.","DOI":"10.7863\/jum.2011.30.6.833"},{"key":"5457_CR7","doi-asserted-by":"publisher","unstructured":"Fievet L, Faure A, Coze S, Harper L, Panait N, Braunstein D et al. Fetal megacystis: etiologies, management, and outcome according to the trimester. Urology. 2014:185-90. https:\/\/doi.org\/10.1016\/j.urology.2014.02.018.","DOI":"10.1016\/j.urology.2014.02.018"},{"key":"5457_CR8","doi-asserted-by":"publisher","unstructured":"Stadi\u00e9 R, Strizek B, Gottschalk I, Geipel A, Gembruch U, Berg C. Intrauterine vesicoamniotic shunting for fetal megacystis. Arch Gynecol Obstet. 2016:1175-82. https:\/\/doi.org\/10.1007\/s00404-016-4152-4.","DOI":"10.1007\/s00404-016-4152-4"},{"key":"5457_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/uog.15844","volume":"48","author":"R Ruano","year":"2016","unstructured":"Ruano R, et al. Fetal lower urinary tract obstruction: proposal for standardized multidisciplinary prenatal management based on disease severity. Ultrasound Obstet Gynecol. 2016;48:476\u201382.","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"5457_CR10","doi-asserted-by":"crossref","unstructured":"Morris RK, Malin GL, Quinlan-Jones E, Middleton LJ, Hemming K, Burke D, et al.; Percutaneous vesicoamniotic shunting in Lower Urinary Tract Obstruction (PLUTO) Collaborative Group. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial. Lancet. 2013; 382(9903): 1496\u201350","DOI":"10.1016\/S0140-6736(13)60992-7"},{"key":"5457_CR11","doi-asserted-by":"crossref","unstructured":"Strizek B, Gottschalk I, Recker F, Weber E, Fl\u00f6ck A, Gembruch et al.\u00a0Vesicoamniotic shunting for fetal megacystis in the first trimester with a Somatex intrauterine shunt. Arch Gynecol Obstet. 2020;302:133\u201340.","DOI":"10.1007\/s00404-020-05598-z"},{"key":"5457_CR12","doi-asserted-by":"publisher","unstructured":"Strizek B, Spicher T, Gottschalk I, B\u00f6ckenhoff P, Simonini C, Berg C, et al.\u00a0Vesicoamniotic Shunting before 17 + 0 Weeks in Fetuses with Lower Urinary Tract Obstruction (LUTO): Comparison of Somatex vs. Harrison Shunt Systems. J Clin Med. 2022;11:2359. https:\/\/doi.org\/10.3390\/jcm11092359","DOI":"10.3390\/jcm11092359"},{"key":"5457_CR13","doi-asserted-by":"publisher","unstructured":"Bildau J, Enzensberger C, Degenhardt J, Kawecki A, Tenzer A, Kohl et al.\u00a0Lower Urinary Tract Obstruction (LUTO) \u2013 Krankheitsbild, pr\u00e4natale Diagnostik und Therapiem\u00f6glichkeiten. Zeitschrift f\u00fcr Geburtshilfe und Neonatologie. 2014;218(1): 18\u201326. https:\/\/doi.org\/10.1055\/s-0034-1367042.","DOI":"10.1055\/s-0034-1367042"},{"key":"5457_CR14","doi-asserted-by":"publisher","unstructured":"Keil C, Bedei I, Sommer L, Koemhoff M, Axt-Fliedner R, K\u00f6hler S, Weber S. Fetal therapy of LUTO (lower urinary tract obstruction) - a follow-up observational study. J Matern Fetal Neonatal Med. 2022;35(25):8536\u201343. https:\/\/doi.org\/10.1080\/14767058.2021.1988562.\u00a0","DOI":"10.1080\/14767058.2021.1988562"},{"key":"5457_CR15","doi-asserted-by":"publisher","unstructured":"Fetal therapy of LUTO (lower urinary tract obstruction) \u2013 a follow-up observational study. J Matern Fetal Neonatal Med. 2022;35(25):8536-43. https:\/\/doi.org\/10.1080\/14767058.2021.1988562.","DOI":"10.1080\/14767058.2021.1988562"},{"key":"5457_CR16","doi-asserted-by":"publisher","unstructured":"Kohaut J, Fischer-Mertens J, Cernaianu G, Schulten D, Holtkamp G, Kohl S et al. Postnatal surgical treatment and complications following intrauterine vesicoamniotic shunting with the SOMATEX\u00ae intrauterine shunt. A single center experience. J Pediatr Urol. (2023):S1477-5131(23)00277-2. https:\/\/doi.org\/10.1016\/j.jpurol.2023.06.027.","DOI":"10.1016\/j.jpurol.2023.06.027"},{"issue":"6","key":"5457_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/s0022-3468(84)80348-6","volume":"19","author":"PL Glick","year":"1984","unstructured":"Glick PL, Harrison MR, Adzick NS, Noall RA, Villa RL. Correction of congenital hydronephrosis in utero IV: in utero decompression prevents renal dysplasia. J Pediatr Surg. 1984;19(6):649\u201357. https:\/\/doi.org\/10.1016\/s0022-3468(84)80348-6.","journal-title":"J Pediatr Surg."},{"key":"5457_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1046\/j.1432-0436.2002.700602.x","volume":"70","author":"TD Piscione","year":"2002","unstructured":"Piscione TD, Rosenblum NG. The moelcular control of renal branching morphogenesis: current knowledge and emerging insights. Differentiation. 2002;70:227\u201346.","journal-title":"Differentiation"},{"issue":"2","key":"5457_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000264293","volume":"11","author":"AF Bierkens","year":"1996","unstructured":"Bierkens AF, Feitz WF, Nijhuis JG, de Wildt MJ, Flos MS, de Vries JD. Early urethral obstruction sequence: a lethal entity? Fetal Diagn Ther. 1996;11(2):137\u201345. https:\/\/doi.org\/10.1159\/000264293.","journal-title":"Fetal Diagn Ther."},{"key":"5457_CR20","doi-asserted-by":"publisher","unstructured":"Smith-Harrison LI, Hougen HY, Timberlake MD, Corbett ST. Current applications of in utero intervention for lower urinary tract obstruction. J Pediatr Urol. 2015:341-7. https:\/\/doi.org\/10.1016\/j.jpurol.2015.07.012.","DOI":"10.1016\/j.jpurol.2015.07.012"},{"key":"5457_CR21","doi-asserted-by":"publisher","unstructured":"Freedman, A L et al. \u201cLong-term outcome in children after antenatal intervention for obstructive uropathies.\u201d Lancet. 1999: 374-7. https:\/\/doi.org\/10.1016\/S0140-6736(98)11006-1","DOI":"10.1016\/S0140-6736(98)11006-1"},{"issue":"6","key":"5457_CR22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.siny.2007.06.005","volume":"12","author":"D Lissauer","year":"2007","unstructured":"Lissauer D, Morris RK, Kilby MD. Fetal lower urinary tract obstruction. Semin Fetal Neonatal Med. 2007;12(6):464\u201370. https:\/\/doi.org\/10.1016\/j.siny.2007.06.005.","journal-title":"Semin Fetal Neonatal Med."},{"issue":"6","key":"5457_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/00313020310001619145","volume":"35","author":"KC Pringle","year":"2003","unstructured":"Pringle KC, Zuccollo J, Kitagawa H, Koike J, Delahunt B. Renal dysplasia produced by obstructive uropathy in the fetal lamb. Pathology. 2003;35(6):518\u201321. https:\/\/doi.org\/10.1080\/00313020310001619145.","journal-title":"Pathology."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05457-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05457-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05457-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:49:24Z","timestamp":1740379764000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05457-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5457"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05457-3","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"24 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Ruhr-University Bochum (registry no. 23-7779, date of approval: 03\/10\/2023). The need for consent to participate was waived by the Ethics Committee of Ruhr- University Bochum. Ethics approval for this study appropriates national guidelines. Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}